These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3074196)

  • 1. [Antihypertensive treatment with a long-acting formulation of propranolol in the aged].
    Shimamoto Y; Shimamoto H; Nakamura H
    Nihon Ronen Igakkai Zasshi; 1988 May; 25(3):267-72. PubMed ID: 3074196
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies with long acting propranolol.
    Shanks RG
    Postgrad Med J; 1984; 60 Suppl 2():61-8. PubMed ID: 6463010
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of a once daily long-acting formulation of propranolol with conventional propranolol given twice daily in patients with mild to moderate hypertension.
    Douglas-Jones AP
    J Int Med Res; 1979; 7(3):221-3. PubMed ID: 378731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily propranolol for hypertension: a comparison of regular-release, long-acting, and generic formulations.
    Carter BL; Gersema LM; Williams GO; Schabold K
    Pharmacotherapy; 1989; 9(1):17-22. PubMed ID: 2646619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension.
    Serlin MJ; Orme ML; MacIver M; Green GJ; Sibeon RG; Breckenridge AM
    Br J Clin Pharmacol; 1983 May; 15(5):519-27. PubMed ID: 6860527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.
    Bühler FR; Laragh JH; Vaughan ED; Brunner HR; Gavras H; Baer L
    Am J Cardiol; 1973 Sep; 32(4):511-22. PubMed ID: 4729721
    [No Abstract]   [Full Text] [Related]  

  • 7. [Equilibration of the treatment of severe arterial hypertension. Significance of d-1 propranolol].
    Ménard J; Corvol P; Alexandre JM; Meignan M; N'Guyen-Phanh-Tam
    Nouv Presse Med; 1975 Jan; 4(1):17-20. PubMed ID: 806894
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of propranolol and propranolol LA in hypertension using 24-hr noninvasive blood pressure monitoring.
    Rustin MH; Coomes EN
    Postgrad Med J; 1983 Dec; 59(698):770-4. PubMed ID: 6686326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting or conventional propanolol in hypertension?
    Woods JO
    Practitioner; 1979 Dec; 223(1338):834-7. PubMed ID: 396526
    [No Abstract]   [Full Text] [Related]  

  • 11. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.
    Hollifield JW; Sherman K; Zwagg RV; Shand DG
    N Engl J Med; 1976 Jul; 295(2):68-73. PubMed ID: 775330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol LA and ambulatory blood pressure.
    Mann S; Craig MW; Balasubramanian V; Raftery EB
    Br J Clin Pharmacol; 1980 Nov; 10(5):443-7. PubMed ID: 7437256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of sustained release propranolol and results in the treatment of hypertension].
    Levy Y; Kafka M; Brook JG; Halkin H
    Harefuah; 1980 Sep; 99(5-6):125-6. PubMed ID: 7203227
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of a long-acting form of propranolol and conventional propranolol in the treatment of hypertension in elderly patients.
    Khan AU
    J Int Med Res; 1987; 15(3):128-33. PubMed ID: 3301452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of high-renin hypertension with propranolol in children after renal transplantation.
    Potter DE; Schambelan M; Salvatierra O; Orloff S; Holliday MA
    J Pediatr; 1977 Feb; 90(2):307-11. PubMed ID: 318685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
    Zweifler A; Esler M
    Am J Cardiol; 1977 Jul; 40(1):105-9. PubMed ID: 879001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible importance of aldosterone as well as renin in the long-term antihypertensive action of propranolol.
    Drayer JI; Weber MA; Longworth DL; Laragh JH
    Am J Med; 1978 Feb; 64(2):187-92. PubMed ID: 629266
    [No Abstract]   [Full Text] [Related]  

  • 18. Single dose administration of propranolol in hypertension: a comparison of two formulations using clinic and home blood pressure measurements.
    Vandongen R; Beilin LJ; Lalor C; Wall BP
    Aust N Z J Med; 1982 Oct; 12(5):473-7. PubMed ID: 6758744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting propranolol (Inderal LA): pharmacokinetics, pharmacodynamics and therapeutic use.
    Mishriki AA; Weidler DJ
    Pharmacotherapy; 1983; 3(6):334-41. PubMed ID: 6361703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of plasma renin activity and urinary excretion of aldosterone in patients with essential hypertension treated with D-L propranolol].
    Bompiani GD; Scaduto P; Galluzzo A; Morici ML; Mangano MT; Donatelli M
    Minerva Cardioangiol; 1976; 24(7-8):498-505. PubMed ID: 1018743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.